Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy

Thumbnail
Name:
eabe7174.full (1).pdf
Size:
3.888Mb
Format:
PDF
Description:
Publisher's version
Download
Type
Article
Authors
Alsaiari, Shahad K. cc
Qutub, Somayah S. cc
Sun, Shichao cc
Baslyman, Walaa cc
Aldehaiman, Mansour M. cc
Alyami, Mram Z. cc
Almalik, Abdulaziz cc
Halwani, Rabih cc
Merzaban, Jasmeen cc
Mao, Zhengwei cc
Alsaiari, Shahad K. cc
KAUST Department
Advanced Membranes and Porous Materials Research Center
Biological and Environmental Sciences and Engineering (BESE) Division
Bioscience Program
Chemical Science Program
Physical Science and Engineering (PSE) Division
Smart Hybrid Materials (SHMs) Laboratory, Advanced Membranes and Porous Materials Center, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia.
Smart Hybrid Materials (SHMs) lab
Date
2021-01-22
Submitted Date
2020-09-09
Permanent link to this record
http://hdl.handle.net/10754/667120

Metadata
Show full item record
Abstract
The major impediments to the implementation of cancer immunotherapies are the sustained immune effect and the targeted delivery of these therapeutics, as they have life-threatening adverse effects. In this work, biomimetic metal-organic frameworks [zeolitic imidazolate frameworks (ZIFs)] are used for the controlled delivery of nivolumab (NV), a monoclonal antibody checkpoint inhibitor that was U.S. Food and Drug Administration–approved back in 2014. The sustained release behavior of NV-ZIF has shown a higher efficacy than the naked NV to activate T cells in hematological malignancies. The system was further modified by coating NV-ZIF with cancer cell membrane to enable tumor-specific targeted delivery while treating solid tumors. We envisage that such a biocompatible and biodegradable immunotherapeutic delivery system may promote the development and the translation of hybrid superstructures into smart and personalized delivery platforms.
Citation
Alsaiari, S. K., Qutub, S. S., Sun, S., Baslyman, W., Aldehaiman, M., Alyami, M., … Khashab, N. M. (2021). Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy. Science Advances, 7(4), eabe7174. doi:10.1126/sciadv.abe7174
Sponsors
We thank R. Langer, Institute Professor, MIT, for feedback and comments. We acknowledge H. Alrabiah, Associate Professor at the Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University and H. I. Aljohar, Assistant Professor at the Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University for providing nivolumab.
This work was funded by the King Abdulaziz City for Science and Technology (KACST) through the MERS-CoV research grant program (number 20-0004), which is a part of the Targeted Research Program (TRP).
Publisher
American Association for the Advancement of Science (AAAS)
Journal
Science Advances
DOI
10.1126/sciadv.abe7174
Additional Links
https://advances.sciencemag.org/lookup/doi/10.1126/sciadv.abe7174
Collections
Articles; Biological and Environmental Sciences and Engineering (BESE) Division; Bioscience Program; Advanced Membranes and Porous Materials Research Center; Physical Science and Engineering (PSE) Division; Chemical Science Program
The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.Government Works. Distributed under a Creative Commons Attribution Non Commercial License 4.0 (CC BY-NC).
Except where otherwise noted, this item's license is described as The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.Government Works. Distributed under a Creative Commons Attribution Non Commercial License 4.0 (CC BY-NC).